0001493152-23-003343.txt : 20230201
0001493152-23-003343.hdr.sgml : 20230201
20230201180645
ACCESSION NUMBER: 0001493152-23-003343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221209
FILED AS OF DATE: 20230201
DATE AS OF CHANGE: 20230201
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GOWER BOB G
CENTRAL INDEX KEY: 0001136466
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38306
FILM NUMBER: 23578122
MAIL ADDRESS:
STREET 1: 402 TIMBERWILDE LANE
CITY: HOUSTON
STATE: TX
ZIP: 77024
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ensysce Biosciences, Inc.
CENTRAL INDEX KEY: 0001716947
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 822755287
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7946 IVANHOE AVENUE
STREET 2: SUITE 201
CITY: LA JOLLA
STATE: CA
ZIP: 92037
BUSINESS PHONE: (858) 263-4196
MAIL ADDRESS:
STREET 1: 7946 IVANHOE AVENUE
STREET 2: SUITE 201
CITY: LA JOLLA
STATE: CA
ZIP: 92037
FORMER COMPANY:
FORMER CONFORMED NAME: Leisure Acquisition Corp.
DATE OF NAME CHANGE: 20170913
4
1
ownership.xml
X0306
4
2022-12-09
0
0001716947
Ensysce Biosciences, Inc.
ENSC
0001136466
GOWER BOB G
C/O ENSYSCE BIOSCIENCES, INC.
7946 IVANHOE AVENUE, SUITE 201
LA JOLLA
CA
92037
1
0
0
0
Common Stock
2022-12-09
4
P
0
357143
1.40
A
753095
D
Warrants
1.40
2022-12-09
4
A
0
714286
A
2027-12-09
Common Stock
714286
716365
D
On October 28, 2022, Ensysce Biosciences, Inc. (the "Company"), pursuant to an amendment to the Company's Third Amended and Restated Certificate of Incorporation, effectuated a one-for-twenty reverse stock split of the Company's common stock, par value $0.0001 (the "Common Stock").
On December 9, 2022, Mr. Gower purchased 357,143 shares of Common Stock at a price of $1.40 per share.
On December 9, 2022, Mr. Gower purchased 357,143 warrants to purchase 714,286 shares of Common Stock with an exercise price of $1.40 per share (the "Warrants") in an underwritten offering further described on the Company's Prospectus filed pursuant to Rule 424(b)(4) (File No. 333-268038) filed with the Commission on December 9, 2022. The Warrants are immediately exercisable and may be exercised until five years from the date of issuance.
/s/ Bob G Gower
2023-02-01